Extracellular vesicles and microRNAs in Bioactive Materials
Published 07 January, 2025
Extracellular vesicles (EVs) and microRNAs (miRNAs) are emerging as pivotal players in the fields of regenerative medicine, drug delivery, and diagnostics, offering groundbreaking opportunities for advancing theranostic applications. Moreover, microRNA was the subject of 2024 Nobel Prize in Medicien and Physiology. This special issue focuses on the intersection of EVs, miRNAs, and biomaterials, highlighting their synergistic potential to transform the landscape of precision medicine. The scope of this issue also encompasses the engineering and design of smart biomaterials—such as nanomaterials, hydrogels, and tissue scaffolds—that interact with EVs and miRNAs. By fostering collaborations across materials science, molecular biology, and clinical medicine, this issue aims to accelerate breakthroughs in EV- and miRNA-based technologies, paving the way for next-generation biomaterial applications in precision medicine, regenerative therapies, and beyond.
- MicroRNAs in EV-based theranostics
- EV engineering for improved drug delivery and therapeutic efficacy
- Development of biomaterial-based platforms for miRNA and EV delivery
- The role of EV-biomaterial interactions in enhancing tissue regeneration and repair
- Smart biomaterials/devices enabling controlled and sustained release of EVs or miRNAs
- Submission deadline: 12/31/2025
Please read the [Guide for Authors ] before submitting. All articles should be [submitted online], please select [EVs and miRNAs in bioactive materials] on submission.
Ke Cheng
Affiliation: Columbia University
Email: kc3727@columbia.edu
Mengrui Liu
Affiliation: Columbia University
Email: ml5081@columbia.edu
Kaiyue Zhang
Affiliation: Columbia University
Email: kz2518@columbia.edu
